Fill in the form below and our experts will get back to you within 1 business day.
Transform microorganisms into efficient cell factories through systematic pathway engineering, CRISPR-based genome editing, and data-driven metabolic optimization. Our DBTL-driven workflow accelerates strain development.
Trusted by leading research and pharmaceutical institutions
High-efficiency knockout and knock-in
Up to 15 kb seamless integration
E. coli, yeast, Bacillus, and more
We combine cutting-edge synthetic biology tools with proven fermentation expertise to deliver engineered microbial strains optimized for your specific production targets.
Advanced CRISPR-Cas9 and CRISPRi systems enable precise genome edits with up to 95% editing efficiency across multiple microbial hosts.
Design-Build-Test-Learn cycle accelerates strain development through iterative optimization and high-throughput screening.
From E. coli to yeast and Bacillus, we engineer the optimal chassis for your target product spectrum.
Scarless genome edits with up to 3 simultaneous targets.
Seamless Golden Gate and Gibson assembly up to 15 kb.
Screen up to 10^8 variants per round.
NGS verification and comprehensive documentation.
Get a custom pathway design proposal within 48 hours
Our integrated platform combines multiple state-of-the-art tools for comprehensive strain engineering.
Our comprehensive CRISPR toolbox enables precise genome modifications across multiple species with high efficiency.
Advanced computational tools accelerate pathway design and predict optimal engineering targets.
Directed evolution and rational design for enhanced enzyme activity, stability, and specificity.
Sensor-regulator systems for autonomous pathway control and metabolic burden minimization.
Organelle targeting to isolate heterologous pathways and reduce metabolic interference.
Long-term laboratory evolution under selective pressure for improved robustness.
Flexible strain engineering packages to match your project requirements.
| Service Type | Gene Size | Host Options |
|---|---|---|
| Pathway Construction | Up to 15 kb | E. coli, Yeast, B. subtilis |
| CRISPR Gene Knockout | Single gene | Multiple hosts |
| Multi-Gene Integration | Up to 5 genes | E. coli, Yeast |
| Metabolic Flux Optimization | Full pathway | Custom chassis |
| Combinatorial Library | Up to 10 variants | Per specification |
* Specifications are for reference only. Actual performance may vary depending on project complexity and host organism. Contact our team for customized project design.
A systematic approach from consultation to strain delivery.
Computational pathway analysis and target identification
Gene synthesis, CRISPR editing, and clone verification
High-throughput screening and performance evaluation
Data analysis, model refinement, and optimization
Engineered microbial strains powering innovation across sectors.
Engineer microbial cell factories for sustainable biofuel production from renewable feedstocks.
Produce complex pharmaceutical compounds through heterologous pathway expression.
Develop microbial platforms for cost-effective production of industrially relevant chemicals.
Create GRAS-status microbial strains for food-grade compound production.
"The CRISPR-based knockout service delivered strains with exceptional editing efficiency. Our pathway optimization project was completed successfully."
"Their metabolic modeling expertise helped us identify non-obvious targets for flux optimization. The engineered yeast strain achieved higher titer than our in-house development."
"Excellent technical support throughout the project. The DBTL workflow kept us informed at every stage, and the final strains exceeded performance expectations."
Our platform is validated by peer-reviewed research published in leading scientific journals.
This review focuses on strategies to balance cell growth and product synthesis in microbial cell factories, systematically summarizing cutting-edge approaches including pathway engineering, dynamic regulation, and orthogonal systems design.
View DOIGECKO 2.0 toolbox allows integration of enzyme constraints and proteomics data into genome-scale metabolic models for more accurate phenotypic predictions.
View DOIGrowth-coupled selection strategy accelerates cell factory development by linking product synthesis to cell growth for automatic high-producer selection.
View DOICRISPR/Cas9-based method for multiplexed multi-gene integration in yeast, achieving 90-100% success rate for 12-gene plant isoflavonoid pathway integration.
View DOICRISPR-Cas9 system engineering multiple modules to improve artemisinin precursor amorphadiene production, increasing yield from 81 to 116 mg/L.
View DOIFind answers to common questions about our metabolic engineering services.
Get a customized quote for your Metabolic Engineering and Pathway Design Service project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.